Stockhead’s Fraser Palamara chats with AdAlta (ASX:1AD) managing director Tim Oldham to get the short end of the long story on the company’s latest news.

The company announced it’s prioritising its East to West strategy in a bid to to gain a strong foothold in the rapidly growing market of cellular immunotherapies.

Tune in to hear Tim speak on the what the strategy is all about, the market opportunity for T-cell therapies in solid cancers, and more.

 

This video was developed in collaboration with AdAlta, a Stockhead advertiser at the time of publishing.

The interviews and discussions in this video are opinions only and not financial or investment advice. Viewers should obtain independent advice based on their own circumstances before making any financial decisions.

Read MoreHealth

Featured Companies

You might be interested in